Profile image
Senior Research Fellow

Dr Dorothy Machalek

E-mail
dmachalek@kirby.unsw.edu.au
Haqshenas G; Molano M; Phillips S; Balgovind P; Garland SM; Hawkes D; Brotherton JML; Machalek DA; Murray G, 2024, 'Evaluation of Seegene Anyplex II Performance for Detection of Human Papillomavirus Genotypes in Formalin-Fixed, Paraffin-Embedded Cervical Cancer Specimens', Archives of Pathology and Laboratory Medicine, 148, pp. 353 - 358, http://dx.doi.org/10.5858/arpa.2022-0317-OA
2024
Balgovind P; Murray G; Machalek DA; Garland SM; Azzato F; Hinaut JA; Danielewski J; Molano M; Haqshenas G, 2024, 'Seegene Anyplex II assays detect HPV consistently using DNA extracts from different extraction methods', Letters in Applied Microbiology, 77, http://dx.doi.org/10.1093/lambio/ovae045
2024
Htaik K; Vodstrcil LA; Plummer EL; Sfameni AM; Machalek DA; Manhart LE; Bradshaw CS, 2024, 'Systematic review and meta-analysis of the association between Mycoplasma genitalium and Pelvic inflammatory disease (PID).', Clin Infect Dis, http://dx.doi.org/10.1093/cid/ciae295
2024
Murray GL; Plummer EL; Bodiyabadu K; Vodstrcil LA; Huaman JL; Danielewski JA; Chua TP; Machalek DA; Garland S; Doyle M; Sweeney EL; Whiley DM; Bradshaw CS, 2023, 'gyrA Mutations in Mycoplasma genitalium and Their Contribution to Moxifloxacin Failure: Time for the Next Generation of Resistance-Guided Therapy', Clinical Infectious Diseases, 76, pp. 2187 - 2195, http://dx.doi.org/10.1093/cid/ciad057
2023
Bodiybadu K; Danielewski J; Plummer E; Bradshaw CS; Machalek DA; Garland SM; Vodstrcil LA; Murray GL, 2023, 'Comparison of Seegene AnyPlexTMII STI-7e with standard-of-care diagnostic methods for the detection of Mycoplasma genitalium, Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis', Letters in Applied Microbiology, 76, http://dx.doi.org/10.1093/lambio/ovac002
2023
Roberts JM; Machalek DA; Butler BC; Crescini J; Garland SM; Farnsworth A, 2023, 'Older women testing positive for HPV16/18 on cervical screening and risk of high-grade cervical abnormality', International Journal of Cancer, 152, pp. 1593 - 1600, http://dx.doi.org/10.1002/ijc.34393
2023
Brotherton JML; McDermott T; Smith MA; Machalek DA; Shilling H; Prang KH; Jennett C; Nightingale C; Zammit C; Pagotto A; Rankin NM; Kelaher M, 2023, 'Implementation of Australia's primary human papillomavirus (HPV) cervical screening program: The STakeholders Opinions of Renewal Implementation and Experiences Study', Preventive Medicine Reports, 33, http://dx.doi.org/10.1016/j.pmedr.2023.102213
2023
Phillips S; Cornall AM; Molano M; Jin F; Roberts JM; Farnsworth A; Hillman RJ; Templeton DJ; Poynten IM; Garland SM; Fairley CK; Murray GL; Tabrizi SN; Grulich AE; Machalek DA, 2023, 'Performance of Human Papillomavirus Attribution Algorithms to Predict Causative Genotypes in Anal High-Grade Lesions', Journal of Infectious Diseases, 227, pp. 1407 - 1416, http://dx.doi.org/10.1093/infdis/jiac503
2023
Sharma K; Machalek DA; Toh ZQ; Amenu D; Muchengeti M; Ndlovu AK; Mremi A; Mchome B; Vallely AJ; Denny L; Rees H; Garland SM, 2023, 'No woman left behind: achieving cervical cancer elimination among women living with HIV', The Lancet HIV, 10, pp. e412 - e420, http://dx.doi.org/10.1016/S2352-3018(23)00082-6
2023
Peh CR; Danielewski J; Chua TP; Bodiyabadu K; Machalek DA; Garland SM; Bradshaw CS; Murray GL, 2023, 'Quantitation of Mycoplasma genitalium using droplet digital PCR', Letters in Applied Microbiology, 76, http://dx.doi.org/10.1093/lambio/ovad064
2023
Lee J; Ismail-Pratt I; Machalek DA; Kumarasamy S; Garland SM, 2023, 'The recovery strategies to support cervical cancer elimination in lower-and middle-income countries (LMICs) following COVID-19 disruptions', Preventive Medicine Reports, 35, http://dx.doi.org/10.1016/j.pmedr.2023.102291
2023
Palmer M; Katanoda K; Saito E; Acuti Martellucci C; Tanaka S; Ikeda S; Sakamoto H; Machalek D; Brotherton JML; Hocking JS, 2023, 'Corrigendum to “Genotype prevalence and age distribution of human papillomavirus from infection to cervical cancer in Japanese women: A systematic review and meta-analysis” [Vaccine 40(41) (2022) 5971–5996, (S0264410X22009501), (10.1016/j.vaccine.2022.07.052)]', Vaccine, 41, pp. 6135, http://dx.doi.org/10.1016/j.vaccine.2023.06.084
2023
Bavor C; Brotherton JM; Smith MA; Prang KH; McDermott T; Rankin NM; Zammit CM; Jennett CJ; Sultana F; Machalek DA; Nightingale CE, 2023, 'The early impacts of primary HPV cervical screening implementation in Australia on the pathology sector: a qualitative study', BMC Health Services Research, 23, http://dx.doi.org/10.1186/s12913-023-10040-6
2023
Gandelin M; Tran PL; Chirpaz E; Jaffar-Bandjee MC; Traversier N; Machalek D; Bertolotti A, 2023, 'Human Papillomavirus (HPV) Infections Among Participants Undergoing Chlamydia trachomatis Testing in Reunion Island (RUN-SurV-HPV Study): Protocol for a Prevalence Study', JMIR Research Protocols, 12, http://dx.doi.org/10.2196/47379
2023
Haqshenas G; Garland SM; Balgovind P; Cornall A; Danielewski J; Molano M; Machalek DA; Murray G, 2023, 'Development of a touchdown droplet digital PCR assay for the detection and quantitation of human papillomavirus 16 and 18 from self-collected anal samples', Microbiology Spectrum, 11, http://dx.doi.org/10.1128/spectrum.01836-23
2023
Shilling HS; Garland SM; Costa AM; Marceglia A; Fethers K; Danielewski J; Murray G; Bradshaw C; Vodstrcil L; Hocking JS; Kaldor J; Guy R; MacHalek DA, 2022, 'Chlamydia trachomatis and Mycoplasma genitalium prevalence and associated factors among women presenting to a pregnancy termination and contraception clinic, 2009-2019', Sexually Transmitted Infections, 98, pp. 115 - 120, http://dx.doi.org/10.1136/sextrans-2020-054695
2022
Phillips S; Cassells K; Garland SM; Machalek DA; Roberts JM; Templeton DJ; Jin F; Poynten IM; Hillman RJ; Grulich AE; Murray GL; Tabrizi SN; Molano M; Cornall AM, 2022, 'Gene methylation of CADM1 and MAL identified as a biomarker of high grade anal intraepithelial neoplasia', Scientific Reports, 12, http://dx.doi.org/10.1038/s41598-022-07258-5
2022
MacHalek D; Rees H; Chikandiwa A; Munthali R; Travill D; Mbulawa Z; Petoumenos K; Delany-Moretlwe S; Kaldor J, 2022, 'Impact of one and two human papillomavirus (HPV) vaccine doses on community-level HPV prevalence in South African adolescent girls: Study protocol and rationale for a pragmatic before-after design', BMJ Open, 12, http://dx.doi.org/10.1136/bmjopen-2021-059968
2022
Vette KM; Machalek DA; Gidding HF; Nicholson S; O'Sullivan MVN; Carlin JB; Downes M; Armstrong L; Beard FH; Dwyer DE; Gibb R; Gosbell IB; Hendry AJ; Higgins G; Hirani R; Hueston L; Irving DO; Quinn HE; Shilling H; Smith D; Kaldor JM; Macartney K, 2022, 'Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibodies in Australia after the First Epidemic Wave in 2020: A National Survey', Open Forum Infectious Diseases, 9, http://dx.doi.org/10.1093/ofid/ofac002
2022
Catlett B; Starr M; Machalek DA; Danwilai T; Palmer M; Kelly A; Kaldor J; Dore GJ; Darley D; Matthews G; Cunningham PH, 2022, 'Evaluation of serological assays for SARS-CoV-2 antibody testing from dried blood spots collected from cohorts with prior SARS-CoV-2 infection: SARS-CoV-2 detection from dried blood spots', Journal of Clinical Virology Plus, 2, http://dx.doi.org/10.1016/j.jcvp.2022.100093
2022
Chua TP; Danielewski J; Bodiyabadu K; Bradshaw CS; Machalek DA; Garland SM; Plummer EL; Vodstrcil LA; Murray GL, 2022, 'Impact of 16S rRNA Single Nucleotide Polymorphisms on Mycoplasma genitalium Organism Load with Doxycycline Treatment', Antimicrobial Agents and Chemotherapy, 66, http://dx.doi.org/10.1128/aac.00243-22
2022
Murray GL; Bodiyabadu K; Vodstrcil LA; Machalek DA; Danielewski J; Plummer EL; Garland SM; Whiley DM; Sweeney EL; Bradshaw CS, 2022, 'parC Variants in Mycoplasma genitalium: Trends over Time and Association with Moxifloxacin Failure', Antimicrobial Agents and Chemotherapy, 66, http://dx.doi.org/10.1128/aac.00278-22
2022
Machalek DA; Vette KM; Downes M; Carlin JB; Nicholson S; Hirani R; Irving DO; Gosbell IB; Gidding HF; Shilling H; Aung E; Macartney K; Kaldor JM, 2022, 'Serological testing of blood donors to characterise the impact of COVID-19 in Melbourne, Australia, 2020', PLoS ONE, 17, http://dx.doi.org/10.1371/journal.pone.0265858
2022
Poynten IM; Jin F; Roberts JM; Templeton DJ; Law C; Cornall AM; Molano M; Machalek DA; Carr A; Farnsworth A; Tabrizi S; Phillips S; Fairley CK; Garland SM; Hillman RJ; Grulich AE, 2022, 'The Natural History of Anal High-grade Squamous Intraepithelial Lesions in Gay and Bisexual Men (vol 72, pg 853, 2021)', CLINICAL INFECTIOUS DISEASES, 74, http://dx.doi.org/10.1093/cid/ciac150
2022
Poynten IM; Jin F; Molano M; Machalek DA; Roberts JM; Hillman RJ; Cornall A; Phillips S; Templeton DJ; Law C; Fairley CK; Grulich AE; Garland SM, 2022, 'Comparison of four assays for human papillomavirus detection in the anal canal', Clinical Microbiology and Infection, 28, pp. 1652.e1 - 1652.e6, http://dx.doi.org/10.1016/j.cmi.2022.06.027
2022
Zammit CM; Creagh NS; McDermott T; Smith MA; Machalek DA; Jennett CJ; Prang KH; Sultana F; Nightingale CE; Rankin NM; Kelaher M; Brotherton JML, 2022, '“So, if she wasn’t aware of it, then how would everybody else out there be aware of it?”—Key Stakeholder Perspectives on the Initial Implementation of Self-Collection in Australia’s Cervical Screening Program: A Qualitative Study', International Journal of Environmental Research and Public Health, 19, http://dx.doi.org/10.3390/ijerph192315776
2022
Shilling H; Garland SM; Atchison S; Cornall AM; Brotherton JML; Bateson D; McNamee K; Kaldor JM; Hocking JS; Chen MY; Fairley CK; McNulty A; Bell C; Marshall L; Ooi C; Skinner SR; Murray G; Molano M; Tabrizi S; Machalek DA, 2021, 'Human papillomavirus prevalence and risk factors among Australian women 9–12 years after vaccine program introduction', Vaccine, 39, pp. 4856 - 4863, http://dx.doi.org/10.1016/j.vaccine.2021.07.005
2021
Chow EPF; Tabrizi SN; Fairley CK; Wigan R; Machalek DA; Garland SM; Cornall AM; Atchison S; Hocking JS; Bradshaw CS; Balgovind P; Murray GL; Chen MY, 2021, 'Prevalence of human papillomavirus in young men who have sex with men after the implementation of gender-neutral HPV vaccination: a repeated cross-sectional study', The Lancet Infectious Diseases, 21, pp. 1448 - 1457, http://dx.doi.org/10.1016/S1473-3099(20)30687-3
2021
Chow EPF; Carter A; Vickers T; Fairley CK; McNulty A; Guy RJ; Regan DG; Grulich AE; Callander D; Khawar L; Machalek DA; Donovan B, 2021, 'Effect on genital warts in Australian female and heterosexual male individuals after introduction of the national human papillomavirus gender-neutral vaccination programme: an analysis of national sentinel surveillance data from 2004–18', The Lancet Infectious Diseases, 21, pp. 1747 - 1756, http://dx.doi.org/10.1016/S1473-3099(21)00071-2
2021
Brotherton JML; Wheeler C; Clifford GM; Elfström M; Saville M; Kaldor J; Machalek DA, 2021, 'Surveillance systems for monitoring cervical cancer elimination efforts: Focus on HPV infection, cervical dysplasia, cervical screening and treatment', Preventive Medicine, 144, http://dx.doi.org/10.1016/j.ypmed.2020.106293
2021
Poynten IM; Jin F; Roberts JM; Templeton DJ; Law C; Cornall AM; Molano M; MacHalek DA; Carr A; Farnsworth A; Tabrizi S; Phillips S; Fairley CK; Garland SM; Hillman RJ; Grulich AE, 2021, 'The Natural History of Anal High-grade Squamous Intraepithelial Lesions in Gay and Bisexual Men', Clinical Infectious Diseases, 72, pp. 853 - 861, http://dx.doi.org/10.1093/cid/ciaa166
2021
Bodiyabadu K; Danielewski J; Garland SM; Machalek DA; Bradshaw CS; Birnie J; Ebeyan S; Lundgren M; Murray G, 2021, 'Detection of parC gene mutations associated with quinolone resistance in Mycoplasma genitalium: Evaluation of a multiplex real-time PCR assay', Journal of Medical Microbiology, 70, http://dx.doi.org/10.1099/jmm.0.001257
2021
Atchison S; Shilling H; Balgovind P; Machalek DA; Hawkes D; Garland SM; Saville M; Murray G; Molano M; Danielewski J; Phillips S, 2021, 'Evaluation of the Roche MagNA Pure 96 nucleic acid extraction platform for the Seegene Anyplex II HPV28 detection assay', Journal of Applied Microbiology, 131, pp. 2592 - 2599, http://dx.doi.org/10.1111/jam.15126
2021
Chua TP; Bodiyabadu K; Machalek DA; Garland SM; Bradshaw CS; Plummer EL; Danielewski J; Vodstrcil LA; Doyle ML; Murray GL, 2021, 'Prevalence of Mycoplasma genitalium fluoroquinolone-resistance markers, and dual-class-resistance markers, in asymptomatic men who have sex with men', Journal of Medical Microbiology, 70, http://dx.doi.org/10.1099/jmm.0.001429
2021
Gidding HF; Machalek DA; Hendry AJ; Quinn HE; Vette K; Beard FH; Shilling HS; Hirani R; Gosbell IB; Irving DO; Hueston L; Downes M; Carlin JB; O'Sullivan MVN; Dwyer DE; Kaldor JM; Macartney K, 2021, 'Seroprevalence of SARS-CoV-2-specific antibodies in Sydney after the first epidemic wave of 2020', Medical Journal of Australia, 214, pp. 179 - 185, http://dx.doi.org/10.5694/mja2.50940
2021
Khawar L; McManus H; Vickers T; Chow EPF; Fairley CK; Donovan B; Machalek DA; Regan DG; Grulich AE; Guy RJ; McGregor S, 2021, 'Genital warts trends in Australian and overseas-born people in Australia: A cross-sectional trend analysis to measure progress towards control and elimination', The Lancet Regional Health - Western Pacific, 16, pp. 100251, http://dx.doi.org/10.1016/j.lanwpc.2021.100251
2021
Machalek DA; Tao Y; Shilling H; Jensen JS; Unemo M; Murray G; Chow EPF; Low N; Garland SM; Vodstrcil LA; Fairley CK; Hocking JS; Zhang L; Bradshaw CS, 2020, 'Prevalence of mutations associated with resistance to macrolides and fluoroquinolones in Mycoplasma genitalium: a systematic review and meta-analysis', The Lancet Infectious Diseases, 20, pp. 1302 - 1314, http://dx.doi.org/10.1016/S1473-3099(20)30154-7
2020
Latimer RL; Shilling HS; Vodstrcil LA; MacHalek DA; Fairley CK; Chow EPF; Read TRH; Bradshaw CS, 2020, 'Prevalence of Mycoplasma genitalium by anatomical site in men who have sex with men: A systematic review and meta-analysis', Sexually Transmitted Infections, 96, pp. 563 - 570, http://dx.doi.org/10.1136/sextrans-2019-054310
2020
Farnsworth A; Roberts JM; Garland SM; Crescini J; Kaldor JM; Machalek DA, 2020, 'Detection of high-grade cervical disease among women referred directly to colposcopy after a positive HPV screening test varies with age and cytology findings', International Journal of Cancer, 147, pp. 3068 - 3074, http://dx.doi.org/10.1002/ijc.33128
2020
Shilling H; Murray G; Brotherton JML; Hawkes D; Saville M; Sivertsen T; Chambers I; Roberts J; Farnsworth A; Garland SM; Hocking JS; Kaldor J; Guy R; Atchison S; Costa AM; Molano M; Machalek DA, 2020, 'Monitoring human papillomavirus prevalence among young Australian women undergoing routine chlamydia screening', Vaccine, 38, pp. 1186 - 1193, http://dx.doi.org/10.1016/j.vaccine.2019.11.019
2020
Roberts JM; Poynten IM; Molano M; Machalek DA; Hillman RJ; Guzman P; Jin F; Templeton DJ; Fairley CK; Law C; Garland SM; Grulich AE; Cornall AM; Cunningham P, 2020, 'Human papillomavirus genotypes in anal high-grade squamous intraepithelial lesion (HSIL): Anal intraepithelial neoplasia grades 2 (AIN2) and 3 (AIN3) are different', Cancer Epidemiology Biomarkers and Prevention, 29, pp. 2078 - 2083, http://dx.doi.org/10.1158/1055-9965.EPI-20-0664
2020
Khawar L; Machalek DA; Regan DG; Donovan B; McGregor S; Guy RJ, 2020, 'Defining elimination of genital warts—a modified delphi study', Vaccines, 8, pp. 1 - 17, http://dx.doi.org/10.3390/vaccines8020316
2020
Murray GL; Bodiyabadu K; Danielewski J; Garland SM; MacHalek DA; Fairley CK; Jensen JS; Williamson DA; Tan LY; Mokany E; Durukan D; Bradshaw CS, 2020, 'Moxifloxacin and Sitafloxacin Treatment Failure in Mycoplasma genitalium Infection: Association with parC Mutation G248T (S83I) and Concurrent gyrA Mutations', Journal of Infectious Diseases, 221, pp. 1017 - 1024, http://dx.doi.org/10.1093/infdis/jiz550
2020
Murray GL; Danielewski J; Bradshaw CS; Williamson DA; Birnie J; Su JP; De Petra V; Tan LY; Wee R; MacHalek DA; Read TRH; Garland SM, 2020, 'Performance of the ResistancePlus MG diagnostic test for Mycoplasma genitalium using samples collected with Hologic Aptima Specimen Collection kits', Journal of Medical Microbiology, 69, pp. 244 - 248, http://dx.doi.org/10.1099/jmm.0.001140
2020
Murray GL; Doyle M; Bodiyabadu K; Vodstrcil LA; Garland SM; Danielewski J; Machalek DA; McGuinness C; Plummer EL; de Petra V; Williamson DA; Bradshaw CS, 2020, 'Evaluation of ResistancePlus MG FleXible, a 'near-patient' test for the detection of Mycoplasma genitalium and macrolide resistance mutations, using freshly collected clinical samples', Journal of Medical Microbiology, 70, http://dx.doi.org/10.1099/JMM.0.001271
2020
Drolet M; Bénard É; Pérez N; Brisson M; Ali H; Boily MC; Baldo V; Brassard P; Brotherton JML; Callander D; Checchi M; Chow EPF; Cocchio S; Dalianis T; Deeks SL; Dehlendorff C; Donovan B; Fairley CK; Flagg EW; Gargano JW; Garland SM; Grün N; Hansen BT; Harrison C; Herweijer E; Imburgia TM; Johnson AM; Kahn JA; Kavanagh K; Kjaer SK; Kliewer EV; Liu B; Machalek DA; Markowitz L; Mesher D; Munk C; Niccolai L; Nygård M; Ogilvie G; Oliphant J; Pollock KG; Purriños-Hermida MJ; Smith MA; Steben M; Söderlund-Strand A; Sonnenberg P; Sparen P; Tanton C; Wheeler CM; Woestenberg PJ; Yu BN, 2019, 'Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis', The Lancet, 394, pp. 497 - 509, http://dx.doi.org/10.1016/S0140-6736(19)30298-3
2019
Chow EPF; Tabrizi SN; Fairley CK; Wigan R; Machalek DA; Regan DG; Hocking JS; Garland SM; Cornall AM; Atchison S; Bradshaw CS; McNulty A; Owen L; Marshall L; Russell DB; Kaldor JM; Chen MY, 2019, 'Prevalence of human papillomavirus in teenage heterosexual males following the implementation of female and male school-based vaccination in Australia: 2014–2017', Vaccine, 37, pp. 6907 - 6914, http://dx.doi.org/10.1016/j.vaccine.2019.09.052
2019
Machalek DA; Roberts JM; Garland SM; Thurloe J; Richards A; Chambers I; Sivertsen T; Farnsworth A, 2019, 'Routine cervical screening by primary HPV testing: early findings in the renewed National Cervical Screening Program', Medical Journal of Australia, 211, pp. 113 - 119, http://dx.doi.org/10.5694/mja2.50223
2019
Murray GL; Su JP; Birnie J; Danielewski J; Machalek DA; Bradshaw CS; Read TRH; Costa AM; Garland SM, 2019, 'The impact of sample storage on molecular-based detection of Mycoplasma genitalium', Journal of Applied Microbiology, 127, pp. 1219 - 1223, http://dx.doi.org/10.1111/jam.14359
2019
Murray GL; Danielewski J; Bodiyabadu K; Machalek DA; Bradshaw CS; Costa AM; Birnie J; Garland SM, 2019, 'Analysis of infection loads in Mycoplasma genitalium clinical specimens by use of a commercial diagnostic test', Journal of Clinical Microbiology, 57, http://dx.doi.org/10.1128/JCM.00344-19
2019
Brotherton JM; Hawkes D; Sultana F; Malloy MJ; Machalek DA; Smith MA; Garland SM; Saville M, 2019, 'Age-specific HPV prevalence among 116,052 women in Australia's renewed cervical screening program: A new tool for monitoring vaccine impact', Vaccine, 37, pp. 412 - 416, http://dx.doi.org/10.1016/j.vaccine.2018.11.075
2019
Machalek DA; Garland SM; Brotherton JML; Bateson D; McNamee K; Stewart M; Rachel Skinner S; Liu B; Cornall AM; Kaldor JM; Tabrizi SN, 2018, 'Very Low Prevalence of Vaccine Human Papillomavirus Types among 18- to 35-Year Old Australian Women 9 Years Following Implementation of Vaccination', Journal of Infectious Diseases, 217, pp. 1590 - 1600, http://dx.doi.org/10.1093/infdis/jiy075
2018
Elder K; Nickson C; Pattanasri M; Cooke S; Machalek D; Rose A; Mou A; Collins JP; Park A; De Boer R; Phillips C; Pridmore V; Farrugia H; Bruce Mann G, 2018, 'Treatment Intensity Differences After Early-Stage Breast Cancer (ESBC) Diagnosis Depending on Participation in a Screening Program', Annals of Surgical Oncology, 25, pp. 2563 - 2572, http://dx.doi.org/10.1245/s10434-018-6469-7
2018
Pattanasri M; Elder K; Nickson C; Cooke S; Machalek D; Rose A; Mou A; Collins JP; Park A; De Boer R; Phillips C; Pridmore V; Farrugia H; Mann GB, 2018, 'Uptake of adjuvant breast cancer treatments recommended by multi-disciplinary meetings', ANZ Journal of Surgery, 88, pp. 745 - 750, http://dx.doi.org/10.1111/ans.14368
2018
Roberts JM; Molano M; Thurloe JK; Hillman RJ; Templeton DJ; Law C; Mary Poynten I; Jin F; Guzman P; Garland SM; Machalek DA; Grulich AE; Cornall AM, 2018, 'Correlation between HPV16 positivity on anal swab and biopsy-confirmed HSIL caused by HPV16 in the study of the prevention of anal cancer (SPANC)', Papillomavirus Research, 5, pp. S13 - S13, http://dx.doi.org/10.1016/j.pvr.2018.07.031
2018
Chow EPF; Machalek DA; Tabrizi SN; Danielewski JA; Fehler G; Bradshaw CS; Garland SM; Chen MY; Fairley CK, 2017, 'Quadrivalent vaccine-targeted human papillomavirus genotypes in heterosexual men after the Australian female human papillomavirus vaccination programme: a retrospective observational study', The Lancet Infectious Diseases, 17, pp. 68 - 77, http://dx.doi.org/10.1016/S1473-3099(16)30116-5
2017
Machalek DA; Chow EPF; Garland SM; Wigan R; Cornall AM; Fairley CK; Kaldor JM; Hocking JS; Williams H; McNulty A; Bell C; Marshall L; Ooi C; Chen MY; Tabrizi SN; Regan D, 2017, 'Human Papillomavirus Prevalence in Unvaccinated Heterosexual Men after a National Female Vaccination Program', Journal of Infectious Diseases, 215, pp. 202 - 208, http://dx.doi.org/10.1093/infdis/jiw530
2017
Cornall AM; Poljak M; Garland SM; Phillips S; Tan JH; Machalek DA; Quinn MA; Tabrizi SN, 2017, 'Anyplex II HPV28 detection and Anyplex II HPV HR detection assays are highly concordant with other commercial assays for detection of high-risk HPV genotypes in women with high grade cervical abnormalities', European Journal of Clinical Microbiology and Infectious Diseases, 36, pp. 545 - 551, http://dx.doi.org/10.1007/s10096-016-2831-5
2017
Poynten IM; Tabrizi SN; Jin F; Templeton DJ; Machalek DA; Cornall A; Phillips S; Fairley CK; Garland SM; Law C; Carr A; Hillman RJ; Grulich AE, 2017, 'Vaccine-preventable anal human papillomavirus in Australian gay and bisexual men', Papillomavirus Research, 3, pp. 80 - 84, http://dx.doi.org/10.1016/j.pvr.2017.02.003
2017
Jin F; Roberts JM; Grulich AE; Poynten IM; MacHalek DA; Cornall A; Phillips S; Ekman D; McDonald RL; Hillman RJ; Templeton DJ; Farnsworth A; Garland SM; Fairley CK; Tabrizi SN; Law C; Biro C; Richards A; Thurloe J; Adams M; McCaffery K; Howard K; Kelly P; Seeds D; Garcia M; Carr A; Feeney L; Gluyas R; Prestage G; Petoumenos K; Law M; Acraman B; McGrath P; Mellor R; Pezzopane P, 2017, 'The performance of human papillomavirus biomarkers in predicting anal high-grade squamous intraepithelial lesions in gay and bisexual men', AIDS, 31, pp. 1303 - 1311, http://dx.doi.org/10.1097/QAD.0000000000001462
2017
Templeton DJ; Roberts JM; Poynten IM; Law C; Hillman RJ; Farnsworth A; Fairley CK; Tabrizi SN; Garland SM; Grulich AE; Jin F; Acraman B; Carr A; Carroll S; Cooper D; Cornall A; Crampton L; Fairley K; Feeney L; Fraissard E; Howard K; Law M; MacHalek D; McCaffery K; McGrath P; Mellor R; Norris R; O'Dwyer M; Pendlebury S; Petoumenos K; Phillips S; Prestage G; Richards A; Schema L; Seeds D; Segelov E; Thurloe J; Tong W; Varma R, 2017, 'Prevalence and predictors of unsatisfactory anal cytology tests in a cohort of gay and bisexual men in Sydney, Australia: Baseline findings from the Study of the Prevention of Anal Cancer (SPANC)', European Journal of Cancer Prevention, 26, pp. 212 - 216, http://dx.doi.org/10.1097/CEJ.0000000000000321
2017
MacHalek DA; Wark JD; Tabrizi SN; Hopper JL; Bui M; Dite GS; Cornall AM; Pitts M; Gertig D; Erbas B; Garland SM, 2017, 'Genetic and Environmental Factors in Invasive Cervical Cancer: Design and Methods of a Classical Twin Study', Twin Research and Human Genetics, 20, pp. 10 - 18, http://dx.doi.org/10.1017/thg.2016.93
2017
Das R; Machalek DA; Molesworth EG; Garland SM, 2017, 'Using Facebook to recruit young Australian men into a cross-sectional human papillomavirus study', Journal of Medical Internet Research, 19, http://dx.doi.org/10.2196/jmir.8739
2017
Cornall AM; Poljak M; Garland SM; Phillips S; Machalek DA; Tan JH; Quinn MA; Tabrizi SN, 2017, 'HPV genotype-specific concordance between EuroArray HPV, Anyplex II HPV28 and Linear Array HPV Genotyping test in Australian cervical samples', Papillomavirus Research, 4, pp. 79 - 84, http://dx.doi.org/10.1016/j.pvr.2017.10.002
2017
Garland SM; Machalek DA, 2017, 'Maximizing the impact of human papillomavirus vaccination', Clinical Infectious Diseases, 65, pp. 890 - 892, http://dx.doi.org/10.1093/cid/cix459
2017
Phillips S; Cornall AM; Machalek DA; Garland SM; Bateson D; Garefalakis M; Tabrizi SN, 2016, 'Comparison of the roche cobas® 4800 HPV assay to roche amplicor for detection of high-risk human papillomavirus', European Journal of Clinical Microbiology and Infectious Diseases, 35, pp. 1305 - 1307, http://dx.doi.org/10.1007/s10096-016-2665-1
2016
Cornall AM; Poljak M; Garland SM; Phillips S; Machalek DA; Tan JH; Quinn MA; Tabrizi SN, 2016, 'EUROarray human papillomavirus (HPV) assay is highly concordant with other commercial assays for detection of high-risk HPV genotypes in women with high grade cervical abnormalities', European Journal of Clinical Microbiology and Infectious Diseases, 35, pp. 1033 - 1036, http://dx.doi.org/10.1007/s10096-016-2634-8
2016
Roberts JM; Jin F; Thurloe JK; Ekman D; Adams MK; McDonald RL; Biro C; Poynten IM; Grulich AE; Farnsworth A; Aarnsworth R; Acraman B; Carr A; Carroll S; Cooper D; Cornall A; Crampton L; Fairley C; Farnsworth A; Feeney L; Garcia M; Garland S; Gluyas R; Hillman R; Howard K; Lawa F; Law C; Law M; Machalek D; McCaffery K; McGrath P; Mellor R; Pendlebury S; Petoumenos K; Pezzopane P; Phillips S; Mary Poynten I; Prestage G; Richards A; Seeds D; Segelov E; Tabrizi S; Templeton D; Tong W; Varma R, 2016, 'The value of a transformation zone component in anal cytology to detect HSIL', Cancer Cytopathology, 124, pp. 596 - 601, http://dx.doi.org/10.1002/cncy.21730
2016
Hocking JS; Vaughan C; Lau A; MacHelak DA; Graham S, 2016, 'Reducing the burden of sexually transmissible infections in Papua New Guinea requires strengthening of clinical services and engaging men', Sexual Health, 13, pp. 401 - 403, http://dx.doi.org/10.1071/SH16058
2016
Machalek DA; Poynten IM; Jin F; Hillman RJ; Templeton DJ; Law C; Roberts JM; Tabrizi SN; Garland SM; Farnsworth A; Fairley CK; Grulich AE; Acraman B; Adams M; Carr A; Carroll S; Cooper D; Cornall A; Crampton L; Ekman D; Fairley K; Feeney L; Fraissard E; Howard K; Law M; McCaffery K; McDonald R; McGrath P; Mellor R; Norris R; O'Dwyer M; Pendlebury S; Petoumenos K; Phillips S; Prestage G; Richards A; Schema L; Seeds D; Segelov E; Thurloe J; Tong W; Varma R, 2016, 'A composite cytology-histology endpoint allows a more accurate estimate of anal high-grade squamous intraepithelial lesion prevalence', Cancer Epidemiology Biomarkers and Prevention, 25, pp. 1134 - 1143, http://dx.doi.org/10.1158/1055-9965.EPI-15-1106
2016
Poynten IM; Machalek D; Templeton D; Jin F; Hillman R; Zablotzska I; Prestage G; Holt M; Grulich A; Zablotska-Manos I, 2016, 'Comparison of age-specific patterns of sexual behaviour and anal HPV prevalence in homosexual men with patterns in women', Sexually Transmitted Infections, 92, pp. 228 - 231, http://dx.doi.org/10.1136/sextrans-2015-052032
2016
Machalek DA; Jin F; Poynten IM; Hillman RJ; Templeton DJ; Law C; Roberts JM; Tabrizi SN; Garland SM; Farnsworth A; Fairley CK; Grulich AE; Acraman B; Adams M; Carr A; Carroll S; Cooper D; Cornall A; Crampton L; Ekman D; Feeney L; Fraissard E; Howard K; Law M; McCaffery K; McDonald R; McGrath P; Mellor R; Norris R; O'Dwyer M; Pendlebury S; Petoumenos K; Phillips S; Prestage G; Richards A; Schema L; Seeds D; Segelov E; Thurloe J; Tong W; Varma R, 2016, 'Prevalence and risk factors associated with high-grade anal squamous intraepithelial lesions (HSIL)-AIN2 and HSIL-AIN3 in homosexual men', Papillomavirus Research, 2, pp. 97 - 105, http://dx.doi.org/10.1016/j.pvr.2016.05.003
2016
Tung ILY; Machalek DA; Garland SM, 2016, 'Attitudes, knowledge and factors associated with Human Papillomavirus (HPV) vaccine uptake in adolescent girls and young women in Victoria, Australia', PLoS ONE, 11, http://dx.doi.org/10.1371/journal.pone.0161846
2016
Chow E; Machalek D; Tabrizi S; Danielewski J; Fehler G; Bradshaw C; Garland S; Chen M; Fairley C; Walker S, 2016, 'O027 Rapid fall in quadrivalent vaccine targeted human papillomavirus genotypes in heterosexual men following the Australian female HPV vaccination programme: an observational study from 2004 to 2015', Sexually Transmitted Infections, 92, pp. A10.2 - A11, http://dx.doi.org/10.1136/sextrans-2016-052718.26
2016
Garland SM; Molesworth EG; Machalek DA; Cornall AM; Tabrizi SN, 2015, 'How to best measure the effectiveness of male human papillomavirus vaccine programmes?', Clinical Microbiology and Infection, 21, pp. 834 - 841, http://dx.doi.org/10.1016/j.cmi.2015.05.038
2015
Tabrizi SN; Costa AM; Marceglia A; Machalek DA; Bradshaw CS; Chen M; Fairley CK; Garland SM, 2015, 'P07.01 Mycoplasma genitaliumtesting pattern and infection rates over a six-year period in melbourne, australia', Sexually Transmitted Infections, 91, pp. A120.2 - A121, http://dx.doi.org/10.1136/sextrans-2015-052270.317
2015
Cornall AM; Roberts JM; Molano M; Machalek DA; Phillips S; Hillman RJ; Grulich AE; Jin F; Poynten IM; Templeton DJ; Garland SM; Tabrizi SN; Prestage G; Tong W; Varma R, 2015, 'BMJ open: Laser capture microdissection as a tool to evaluate human papillomavirus genotyping and methylation as biomarkers of persistence and progression of anal lesions', BMJ Open, 5, pp. e008439, http://dx.doi.org/10.1136/bmjopen-2015-008439
2015
Machalek DA; Grulich AE; Hillman RJ; Jin F; Templeton DJ; Tabrizi SN; Garland SM; Prestage G; McCaffery K; Howard K; Tong W; Fairley CK; Roberts J; Farnsworth A; Poynten IM, 2013, 'The Study of the Prevention of Anal Cancer (SPANC): Design and methods of a three-year prospective cohort study', BMC Public Health, 13, http://dx.doi.org/10.1186/1471-2458-13-946
2013
Machalek DA; Poynten IM; Jin F; Fairley CK; Farnsworth A; Garland S; Hillman R; Petoumenos K; Roberts J; Tabrizi S; Templeton DJ; Grulich AE, 2012, 'Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: A systematic review and meta-analysis', Lancet Oncology, 13, pp. 487 - 500, http://dx.doi.org/10.1016/S1470-2045(12)70080-3
2012
Machalek DA; Grulich AE; Jin F; Templeton DJ; Poynton IM, 2012, 'The epidemiology and natural history of anal human papillomavirus infection in men who have sex with men', Sexual Health, 9, pp. 527 - 537, http://dx.doi.org/10.1071/SH12043
2012
Grulich AE; Poynten IM; MacHalek DA; Jin F; Templeton DJ; Hillman RJ, 2012, 'The epidemiology of anal cancer', Sexual Health, 9, pp. 504 - 508, http://dx.doi.org/10.1071/SH12070
2012
Grulich AE; Machalek DA; Poynton IM; Jin F; Fairley CK; Tabrizi S; Garland S; Templeton DJ; Hillman R, 2012, 'Anal cancer screening - Authors' reply', Lancet Oncology, 13, pp. E280
2012
Grulich AE; Machalek DA; Poynten IM; Jin F; Fairley CK; Tabrizi SN; Garland SM; Templeton DJ; Hillman RJ, 2012, 'Anal cancer screening Reply', LANCET ONCOLOGY, 13, pp. E280 - E280, http://dx.doi.org/10.1016/S1470-2045(12)70272-3
2012
O'Toole S; Machalek DA; Shearer R; Millar E; Nair R; Schofield PR; McLeod D; Cooper CE; Mcneil CM; Mcfarland A; Nguyen A; Ormandy CJ; Qiu M; Rabinovich B; Martelotto L; Vu D; Hannigan GE; Musgrove EA; Christ DU; Sutherland RL; Watkins DJ; Swarbrick A, 2011, 'Hedgehog overexpression is associated with stromal interactions and predicts for poor outcome in breast cancer', Cancer research, 71, pp. 4002 - 4014, http://dx.doi.org/10.1158/0008-5472.CAN-10-3738
2011
Tanudji M; Machalek D; Arndt GM; Rivory L, 2010, 'Competition Between siRNA Duplexes: Impact of RNA-Induced Silencing Complex Loading Efficiency and Comparison Between Conventional-21 bp and Dicer-Substrate siRNAs', Oligonucleotides, 20, pp. 27 - 32, http://dx.doi.org/10.1089/oli.2009.0195
2010
Molano M; Tabrizi SN; Garland SM; Roberts JM; MacHalek DA; Phillips S; Chandler D; Hillman RJ; Grulich AE; Jin F; Poynten IM; Templeton DJ; Cornall AM; McCaffery K; Howard K; Farnsworth A; Fairley K; Prestage G; Carr A; Tong W; Law C; Acraman B; Crampton L; Feeney L; Fraissard E; Law M; McGrath P; Mellor R; Norris R; O'Dwyer M; Pendlebury S; Petoumenos K; Richards A; Schema L; Seeds D; Segelov E; Thurloe J; Varma R; Han A, 2010, 'CpG methylation analysis of hpv16 in laser capture microdissected archival tissue and whole tissue sections from high grade anal squamous intraepithelial lesions: A potential disease biomarker', PLoS ONE, 11, pp. e0160673, http://dx.doi.org/10.1371/journal.pone.0160673
2010
Lawson VA; Lumicisi B; Welton J; Machalek D; Gouramanis K; Klemm HM; Stewart JD; Masters CL; Hoke DE; Collins SJ; Hill AF, 2010, 'Glycosaminoglycan sulphation affects the seeded misfolding of a mutant prion protein', PLoS ONE, 5, http://dx.doi.org/10.1371/journal.pone.0012351
2010
Lawson VA; Vella LJ; Stewart JD; Sharples RA; Klemm H; Machalek DM; Masters CL; Cappai R; Collins SJ; Hill AF, 2008, 'Mouse-adapted sporadic human Creutzfeldt-Jakob disease prions propagate in cell culture', International Journal of Biochemistry and Cell Biology, 40, pp. 2793 - 2801, http://dx.doi.org/10.1016/j.biocel.2008.05.024
2008
Bavor C; Brotherton JML; Smith MA; Prang K-H; McDermott T; Rankin NM; Zammit CM; Jennett CJ; Sultana F; Machalek DA; Nightingale CE, 2023, The early impacts of primary HPV cervical screening implementation in Australia on the pathology sector: a qualitative study, , http://dx.doi.org/10.21203/rs.3.rs-3012586/v1
2023
Gandelin M; Tran PL; Chirpaz E; Jaffar-Bandjee M-C; Traversier N; Machalek D; Bertolotti A, 2023, Human Papillomavirus (HPV) Infections Among Participants Undergoing Chlamydia trachomatis Testing in Reunion Island (RUN-SurV-HPV Study): Protocol for a Prevalence Study (Preprint), , http://dx.doi.org/10.2196/preprints.47379
2023
Machalek DA; Vette KM; Downes M; Carlin JB; Nicholson S; Hirani R; Irving DO; Gosbell IB; Gidding HF; Shilling H; Aung E; Macartney K; Kaldor JM, 2022, SEROLOGICAL TESTING OF BLOOD DONORS TO CHARACTERISE THE IMPACT OF COVID-19 IN MELBOURNE, AUSTRALIA, 2020, , http://dx.doi.org/10.1101/2022.03.11.22272185
2022
Khawar L; Vickers T; McManus H; Chow EP; Fairley CK; Donovan B; Machalek DA; Regan DG; Grulich AE; Guy RJ; McGregor S, 2021, 'GENITAL WARTS TRENDS IN AUSTRALIAN AND OVERSEAS-BORN PEOPLE IN AUSTRALIA: MEASURING PROGRESS TOWARDS CONTROL AND ELIMINATION', in SEXUAL HEALTH, CSIRO PUBLISHING, Vol. 18, pp. XXIV - XXIV, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000693686000033&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2021
Templeton DJ; Poynten IM; Jin F; Roberts JM; Law CLH; Cornall AM; Molano M; Machalek DA; Carr A; Farnsworth A; Tabrizi S; Phillips S; Fairley CK; Garland SM; Hillman RJ; Grulich AE, 2019, 'The natural history of anal high grade squamous intraepithelial lesions in HIV positive and HIV negative gay and bisexual men', in HIV MEDICINE, WILEY, Vol. 20, pp. 18 - 18, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000494690300029&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2019
Roberts JM; Molano M; Thurloe JK; Hillman RJ; Templeton DJ; Law C; Poynten IM; Jin F; Guzman P; Garland SM; Machalek DA; Grulich AE; Cornall AM, 2018, '29 Laser capture microdissection-identified HPV genotypes associated with intra-anal high and low-grade intraepithelial lesions', in Tumour Virus Research, Elsevier, Vol. 5, pp. s12, http://dx.doi.org/10.1016/j.pvr.2018.07.030
2018
O'Toole SA; Machalek D; Shearer R; Millar EKA; Nair R; Martelotto L; McLeod D; Cooper C; Qiu MR; Sutherland RL; Watkins DN; Swarbrick A, 2010, 'Hedgehog Ligand Overexpression Predicts Poor Outcome in Breast Cancer and Is a Potential Therapeutic Target for Metastatic Disease', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, Vol. 70, http://dx.doi.org/10.1158/0008-5472.SABCS10-S6-8
2010
Hirani R; Machalek D; Vette K; Gidding H; Shilling H; Nicholson S; O'Sullivan M; Dwyer D; McCartney K; Kaldor J; Gosbell I; Downes M; Carlin J; Irving DO, 2021, 'SEROPREVALENCE OF SARS-CoV-2 IN AUSTRALIAN BLOOD DONORS', in INTERNAL MEDICINE JOURNAL, WILEY, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000722388000050&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2021
Chow E; Tabrizi S; Fairley C; Wigan R; Machalek D; Garland S; Garland S; Atchison S; Hocking J; Bradshaw C; Balgovind P; Murray G; Chen M, 2020, 'DECLINE IN HPV INFECTION AMONG YOUNG MEN WHO HAVE SEX WITH MEN FOLLOWING INTRODUCTION OF GENDER-NEUTRAL VACCINATION IN AUSTRALIA: A REPEAT CROSS-SECTIONAL STUDY', in SEXUALLY TRANSMITTED DISEASES, LIPPINCOTT WILLIAMS & WILKINS, pp. S48 - S48, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000618840600086&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2020
Chow E; Tabrizi S; Fairley C; Wigan R; Regan D; Hocking J; Garland S; Brotherton J; Bradshaw C; Cornall A; McNulty A; Atchison S; Machalek D; Owen L; Marshall L; Russell D; Chen M, 2019, 'PREVALENCE OF HPV IN TEENAGE HETEROSEXUAL MALES AFTER THE INTRODUCTION OF THE GENDER-NEUTRAL VACCINATION PROGRAM IN AUSTRALIA', in SEXUALLY TRANSMITTED INFECTIONS, BMJ PUBLISHING GROUP, pp. A344 - A344, http://dx.doi.org/10.1136/sextrans-2019-sti.864
2019
Machalek D; Shilling H; Atchison S; Cornall A; Brotherton J; Bateson D; Mcnamee K; Hocking J; Kaldor J; Chen M; Fairley C; Chow E; Skinner SR; Murray G; Molano M; Tabrizi S; Garland S, 2019, 'FACTORS ASSOCIATED WITH ONCOGENIC HUMAN PAPILLOMAVIRUS PREVALENCE AMONG AUSTRALIAN WOMEN FOLLOWING VACCINE INTRODUCTION', in SEXUALLY TRANSMITTED INFECTIONS, BMJ PUBLISHING GROUP, pp. A345 - A346, http://dx.doi.org/10.1136/sextrans-2019-sti.867
2019
Latimer R; Shilling H; Vodstrcil L; Machalek D; Fairley C; Read T; Chow E; Bradshaw C, 2019, 'P525 Prevalence ofMycoplasma genitaliumby anatomical site in men who have sex with men: a systematic review and meta-analysis', in Poster Presentations, BMJ Publishing Group Ltd, presented at Abstracts for the STI & HIV World Congress (Joint Meeting of the 23rd ISSTDR and 20th IUSTI), July 14–17, 2019, Vancouver, Canada, http://dx.doi.org/10.1136/sextrans-2019-sti.603
2019
Chow E; Tabrizi S; Fairley C; Wigan R; Cornall A; Atchison S; Machalek D; Hocking J; Bradshaw C; Garland S; Chen M, 2019, 'P501 Low prevalence of high-risk anal HPV in young gay and bisexual males after the universal HPV vaccination program in australia', in Poster Presentations, BMJ Publishing Group Ltd, presented at Abstracts for the STI & HIV World Congress (Joint Meeting of the 23rd ISSTDR and 20th IUSTI), July 14–17, 2019, Vancouver, Canada, http://dx.doi.org/10.1136/sextrans-2019-sti.582
2019
Machalek D; Tao Y; Shilling H; Jensen J; Unemo M; Murray G; Chow E; Low N; Garland S; Fairley C; Vodstrcil L; Hocking J; Zhang L; Bradshaw C, 2019, 'MACROLIDE AND FLUOROQUINOLONE RESISTANCE-ASSOCIATED MUTATIONS IN MYCOPLASMA GENITALIUM: A SYSTEMATIC REVIEW AND META-ANALYSIS', in SEXUALLY TRANSMITTED INFECTIONS, BMJ PUBLISHING GROUP, pp. A266 - A266, http://dx.doi.org/10.1136/sextrans-2019-sti.669
2019
Murray G; Bradshaw C; Bodiyabadu K; Danielewski J; Birnie J; Tan L; Mokany E; Read T; Machalek D; Fairley C; Garland S, 2019, 'MYCOPLASMA GENITALIUM parC AND gyrA MUTATIONS ASSOCIATED WITH MOXIFLOXACIN AND SITAFLOXACIN TREATMENT FAILURE', in SEXUALLY TRANSMITTED INFECTIONS, BMJ PUBLISHING GROUP, pp. A45 - A46, http://dx.doi.org/10.1136/sextrans-2019-sti.125
2019
Elder KJ; Nickson C; Cooke S; Machalek D; Rose A; Mou A; Collins JP; Park A; De Boer R; Phillips C; Pridmore V; Farrugia H; Mann GB, 2018, 'Abstract PD2-13: Benefits to breast screening beyond mortality reduction', in Cancer Research, American Association for Cancer Research (AACR), http://dx.doi.org/10.1158/1538-7445.sabcs17-pd2-13
2018
Elder KJ; Cooke S; Machalek D; Rose A; Mou A; Collins JP; Nickson C; Park A; Mann B, 2015, 'Treatment intensity differences in screen-detected and community-detected early stage breast cancer (ESBC)', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, IL, Chicago, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, IL, Chicago, 29 May 2015 - 02 June 2015, http://dx.doi.org/10.1200/jco.2015.33.15_suppl.1579
2015
Lawson VA; Stewart JD; Machalek DA; Collins SJ; Masters CL; Hill AF, 2005, 'Identification of host factors that affect the formation of the protease resistant form of the prion protein', in JOURNAL OF NEUROCHEMISTRY, WILEY-BLACKWELL PUBLISHING, INC, AUSTRIA, Innsbruck, pp. 146 - 146, presented at 20th Biennial Meeting of the International-Society-for-Neurochemistry/European-Society-for-Neurochemistry, AUSTRIA, Innsbruck, 21 August 2005 - 26 August 2005, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000231673401011&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2005

2020: Kirby Institute Emerging Leader Award

2020: International Papillomavirus Society Travel Award

2019: MJA Prize for Excellence in Medical Research

2016: Seqirus Australia Travel Award

2016: Royal Women’s Hospital Early Career Researcher Award

2013: Australasian Society for HIV Medicine, Australasian HIV & AIDS Conference Best Oral Presentation

2013: Australasian Society for HIV Medicine, Junior Researcher Support Travel Award

2013: Public Health Association of Australia, Aileen Plant Memorial Prize in Infectious Diseases Epidemiology

2012: University of New South Wales, Faculty of Medicine, Dean’s Award for Outstanding Research

2012: University of New South Wales, School of Public Health and Community Medicine Symposium Best Student Oral Presentation

2021: Victorian Department of Health: Serological testing of blood donors to characterise the impact of COVID-19 in Melbourne, 2020

2020: Commonwealth Department of Health: National 2020 SARS-CoV-2 serosurvey

2020: NSW Health Emergency Response Fund: Seroprevalence of SARS-CoV-2-specific antibodies in Sydney, Australia following the first epidemic wave in 2020

2020: University of Melbourne Innovation Grant: Identification of microRNA biomarkers for HPV-related cancer screening

2019-2023: NHMRC Project Grant: Impact of 2-dose and 1-dose HPV vaccination schedules on community level HPV prevalence in South African adolescent girls

2019-2023: Bill and Melinda Gates Foundation: Impact of 2-dose and 1-dose HPV vaccination schedules on community level HPV prevalence in South African adolescent girls

2019-2022: Australian Government Department of Health HPV Surveillance Fund: National HPV Monitoring Program

2017-2021: NHMRC CRE: Centre for Research Excellence in Cervical Cancer Control

2015-2018: Cancer Council Victoria: Evaluating molecular biomarkers of anal cancer risk

2014-2018: Australian Government Department of Health HPV Surveillance Fund: National HPV Monitoring Program

2013-2014: Cure Cancer Australia/Cancer Council NSW Project Grant: HPV biomarkers to predict anal disease progression and persistence